Analysis of blood samples from patients with active RA highlighted differences in cell–cell interactions, altered EMT, and increased TGF-β proteins suggestive of increased de novo ECM synthesis and fibrosis [89]. This evidence concerns the gene TGFB1 and rheumatoid arthritis.